Injectable BPC-157 The injectable form delivers a precise, therapeutic dose and is often recommended for more targeted or intensive recovery support
GLP-1 receptor agonists may be appropriate for select patients with fatty liver disease, particularly those with concurrent metabolic conditions
2035 Mapping Treatment-Induced Adverse Events against HRQoL Questionnaires in Non-Small Cell Lung Cancer: Evaluation of the EORTC QLQ-C30 and QLQ-LC29 Lotte Van der Weijst 1 , Cecilia Pompili 2,3 , Maria Teixeira 4 , Hayat Hamzeh 5 , Claire Piccinin 4 , Madeline Pe 4 1 EORTC, Brussels, Belgium, 2 Institute for Clinical & Applied Health Research, University of Hull, UK, 3 Section of Patient Centred Outcomes Research, University of Leeds, UK, 4 Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium, 5 Leeds Institute of Medical Research, University of Leeds, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2035 Aims This study aims to evaluate the relevance of health-related quality of life (HRQoL) questionnaires in capturing treatment-induced adverse events
)
Effects depend on what the individual is targeting: Immediate (after 1 session): Feeling refreshed Light hydration boost Subtle glow 46 sessions: Noticeable skin clarity More even tone Improved radiance Long-term (8+ sessions): Deeper antioxidant effects Stable brightening Better skin texture and vitality Sun exposure, hydration, and sleep also influence outcomes
